|
[1]LIU M, MIAO T, ZHU H, et al.IL-2-engineered nano-APC effectively activates viral antigen-mediated T cell responses from chronic hepatitis B virus-infected patients[J].J Immunol, 2012, 188 (3) :1534-1543.
|
|
[2]YAO Y, LI J, LU Z, et al.Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.1.5[J].Electrophoresis, 2011, 32 (15) :2004-2012.
|
|
[3]WANG XH, CAO Q, HU CM.JAK/STAT pathway mediates IL-4-induced typeⅠcollagen expression in human hepatic stellate cell line LX-2[J].Basic Clin Med, 2012, 32 (4) :423-427. (in Chinese) 王晓红, 曹琦, 胡成穆.JAK/STAT通路调节IL-4诱导的肝星状细胞系LX-2Ⅰ型胶原基因的表达[J].基础医学与临床, 2012, 32 (4) :423-427.
|
|
[4]KAO JT, LAI HC, TSAI SM, et al.Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in nave hepatitis B infection patients[J].Liver Int, 2012, 32 (6) :928-936.
|
|
[5]ZUO WZ, XU CM, SHEN LC.Changes in serum level of interleukin-32 and interleukin-6 in patients with chronic hepatitis B virus infection and its clinical significance[J].J Clin Hepatol, 2011, 27 (4) :408-410. (in Chinese) 左维泽, 许春梅, 沈兰超.乙型肝炎患者血清白细胞介素-32、白细胞介素-6水平变化及临床意义[J].临床肝胆病杂志, 2011, 27 (4) :408-410.
|
|
[6]WANG MF, YANG WT, YANG GL, et al.The immunoregulatory effects and clinical application[J].Chin J Immunol, 2012, 28 (11) :1046-1050. (in Chinese) 王美芳, 杨文涛, 杨桂连, 等.白细胞介素10的免疫调节作用及临床应用[J].中国免疫学杂志, 2012, 28 (11) :1046-1050.
|
|
[7]MENG J, CHENG SQ.Effects and clinical significance of Entecavir for interleukin-10 and transformer growth factor-βof patients with chronic hepatitis B[J].China Med Herald, 2013, 10 (20) :74-76. (in Chinese) 孟杰, 程书权.恩替卡韦对慢性乙型肝炎患者血清白细胞介素10和转化生长因子β1的影响及临床意义[J].中国医药导报, 2013, 10 (20) :74-76.
|
|
[8]DAS A, ELLIS G, PALLANT C, et al.IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection[J].J Immunol, 2012, 189 (8) :3925-3935.
|
|
[9]SCHURICH A, PALLETT LJ, LUBOWIECKI M, et al.The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells[J].PLoS Pathog, 2013, 9 (3) :e1003208.
|
|
[10]HE D, YAN G, WANG Y.Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection[J].Cell Immunol, 2012, 272 (2) :162-165.
|
|
[11]WU JF, WU TC, CHEN CH, et al.Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion[J].Gastroenterology, 2010, 138 (1) :165-172.
|
|
[12]WANG B, ZHAO XP, FAN YC, et al.IL-17A but not IL-22suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line[J].Antiviral Res, 2013, 97 (3) :285-292.
|
|
[13]ZHANG JY, ZHANG Z, LIN F, et al.Interleukin-17-producing CD4 (+) T cells increase with severity of liver damage in patients with chronic hepatitis B[J].Hepatology, 2010, 51 (1) :81-91.
|
|
[14]DU WJ, ZHEN JH, ZENG ZQ, et al.Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection:IL-17 in HBV infection[J].Diagn Pathol, 2013, 8:40.
|
|
[15]WANG Q, ZHOU J, ZHANG B, et al.Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 Axis[J].PLoS Pathog, 2013, 9 (6) :e1003410.
|
|
[16]TU Z, HAMALAINEN-LAANAYA HK, CRISPE IN, et al.Synergy between TLR3 and IL-18 promotes IFN-γdependent TRAIL expression in human liver NK cells[J].Cell Immunol, 2011, 271 (2) :286-291.
|
|
[17]HE R, LI GJ, WU JZ, et al.IL-18 expression and clinical significance of HBV infection-related chronic liver disease[J].Cur Immunol, 2011, 31 (2) :143-145. (in Chinese) 贺荣, 李国坚, 吴继周, 等.HBV感染相关性慢性肝病IL-18的表达及临床意义研究[J].现代免疫学, 2011, 31 (2) :143-145.
|
|
[18]YAMAMOTO N, MURATA K, YONEDA K, et al.Protective role of interleukin-18 against Fas-mediated liver injury[J].Int J Mol Med, 2008, 22 (1) :43-48.
|
|
[19]ZHANG Y, COBLEIGH MA, LIAN JQ, et al.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus[J].Gastroenterology, 2011, 141 (5) :1897-1906.
|
|
[20]FENG D, KONG X, WENG H, et al.Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection[J].Gastroenterology, 2012, 143 (1) :188-198.
|
|
[21]COBLEIGH MA, ROBEK MD.Protective and pathological properties of IL-22 in liver disease:implications for viral hepatitis[J].Am J Pathol, 2013, 182 (1) :21-28.
|
|
[22]XIANG X, GUI H, KING NJ, et al.IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver[J].Immunol Cell Biol, 2012, 90 (6) :611-619.
|
|
[23]GAO K, ZHANG LF.Interleukin and tumor research progress[J].Chin J Immunol, 2012, 28 (5) :467-473. (in Chinese) 高昆, 张连峰.白细胞介素与肿瘤研究进展[J].中国免疫学杂志, 2012, 28 (5) :467-473.
|
|
[24]WANG HL, ZHANG HY, ZHAI ZL, et al.The correlation between hepatitis B virus infection and IL-27[J].Biomed Mater Eng, 2012, 22 (1-3) :187-193.
|
|
[25]YOSHIMOTO T, YOSHIMOTO T, YASUDA K, et al.IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells:a novel therapeutic way for Th2-mediated allergic inflammation[J].J Immunol, 2007, 179 (7) :4415-4423.
|
DownLoad: